Contact
Please use this form to send email to PR contact of this press release:
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States
TO:
Please use this form to send email to PR contact of this press release:
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States
TO: